Summary CollPlant Holdings Ltd (CollPlant) is a regenerative medicine company that carries out development and commercialization of tissue repair products.The company offers orthobiologics, wound care, and pipeline products.
Its orthobiologics products include VergenixSTR and VergenixBVF.CollPlant’s wound care products include VergenixFG, Vergenix wound dressing.
Its pipeline includes bioink, VergenixTRA, and surgical wounds.CollPlant provides tissue repair products in the areas of orthopedic applications and for advanced wound healing.
The company also provides surgical matrix for spinal fusion and bone trauma, a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote a rapid optimal healing of acute and chronic wounds. CollPlant is headquartered in Ness Ziona, Israel.
CollPlant Ltd (CLGN) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Medical Device Outsourcing Market Research Report by Service (Contract Manufacturing, Product Design and Development Services, Product Implementation Services, Product Maintenance Services, and Product Testing & Sterilization Services), by Therapeutics (Cardiology, Dental, Diabetes care, Drug delivery, and Endoscopy), by Application...
The global refurbished medical equipment market is projected to grow at a CAGR of 11.8%. The global refurbished medical equipment market is projected to reach USD 21.2 billion by 2025 from USD 12.1 billion in 2020, growing at a CAGR of 11.8% from 2020 to 2025. The growth of the global refurbished medical equipment market can be attributed...
257 pages •
By Asia Market Information & Development Company
• May 2020
China’s demand for Health Care has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
The North America software as a medical device market is expected to reach US$ 39,854.20 million by 2027 from US$ 8,353.94 million in 2019. The market is anticipated to grow at a CAGR of 22.2% from 2020 to 2027. The growth of the market is attributed to the increasing adoption of IoT in healthcare and advantages of software as medical device...
The growing funding for cell-based research, rising incidence of chronic and infectious diseases, growing biotechnology and biopharmaceutical industries, and the development of enhanced solutions & improved image analysis will drive market growth. The global cell counting market is estimated to reach USD 14.5 billion by 2025 from USD 10.4...
237 pages •
By Asia Market Information & Development Company
• Apr 2020
China’s demand for Diagnostic Medical Equipment has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer...
Venous Leg Ulcers (Crural Ulcer) Global Clinical Trials Review, H1, 2020 Summary This clinical trial report, “Venous Leg Ulcers (Crural Ulcer) Global Clinical Trials Review, H1, 2020" provides an overview of Venous Leg Ulcers (Crural Ulcer) Clinical trials scenario.This report provides top line data...
High prevalence of diabetes & associated wounds, increasing burn cases, and increasing awareness programs are driving the overall growth of the wound debridement market The wound debridement market is projected to reach a value of USD 1,162 million by 2025 from USD 822 million in 2020, at a CAGR of 7.2% during the forecast period. The growth...
Hepatocyte Growth Factor - Pipeline Review, H1 2020 Summary Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) pipeline Target constitutes close to 15 molecules. The latest report Hepatocyte Growth Factor - Pipeline Review, H1 2020, outlays comprehensive information on the Hepatocyte...
The bioreactors market was valued at US$ 2,958.50 million in 2019 and is projected to reach US$ 5,169.01 million by 2027; it is expected to grow at a CAGR of 7.3% from 2020 to 2027. The increasing adoption of single-use bioreactors, and rapid growth of the pharmaceuticals and biotechnology industries are among the prime factors driving the...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.